Teyi Pharmaceutical Group Co.,Ltd

SZSE:002728 Voorraadrapport

Marktkapitalisatie: CN¥4.6b

Teyi Pharmaceutical GroupLtd Beheer

Beheer criteriumcontroles 0/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur2.4yrs

Recente managementupdates

Recent updates

We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Jun 06
We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt

Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Apr 26
Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems

Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market

Mar 06
Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market

Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching

Feb 27
Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching

CEO

Teyi Pharmaceutical GroupLtd heeft geen CEO, of we hebben geen gegevens over hen.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Songqing Xu
Deputy General Manager & Vice Chairman of The Boardno dataCN¥574.70k8.15%
CN¥ 377.3m
Xiliang Chen
CFO, Deputy GM2.4yrsCN¥557.40kgeen gegevens
Mingjian Zhang
Chairman of the Supervisory Boardno datageen gegevensgeen gegevens
Beijing Lu
Non-Independent Director2.4yrsCN¥87.00kgeen gegevens
Danqing Xu
Chairman & GMno dataCN¥611.50k28.11%
CN¥ 1.3b
Guisheng Li
Independent Director2.4yrsCN¥87.00kgeen gegevens
Jiajun Shen
Shareholder Supervisor2.4yrsgeen gegevensgeen gegevens
Yanming Cao
Independent Director2.4yrsCN¥87.00kgeen gegevens

2.4yrs

Gemiddelde duur

51.5yo

Gemiddelde leeftijd

Ervaren bestuur: 002728's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.